Large brain study challenges simple neural signature of emotional self-control

A 40-dataset analysis finds only limited overlap between people’s reported ability to reframe negative emotions, their feelings during regulation tasks and activity in the brain regions traditionally linked to the process.

A large international meta-analysis published in Nature suggests that the brain systems most often linked to cognitive reappraisal may be less tightly connected to real-world reappraisal skill than many researchers have assumed. The consortium pooled 40 datasets from 32 research teams, covering up to 2,175 healthy participants who had completed task-based fMRI during a reappraisal exercise with negative images or other negative material. The project was designed to test how well self-reported reappraisal ability lines up with brain activity, emotional ratings during the task and amygdala responses, using a common analytical framework across studies.

The findings build on a broader literature that has long treated cognitive reappraisal as one of the best-established emotion-regulation strategies, yet also one that varies widely between people and experimental designs. A previous meta-analysis of emotion-regulation studies showed that different strategies and goals recruit partially distinct neural circuits, while later reviews have underlined that self-reported regulation skill often shows only modest and inconsistent links with neural measures. More recent work has also found that some of the strongest relationships in this area appear in prefrontal regions rather than in the amygdala, adding to the sense that emotion regulation is neurally distributed rather than captured by a single hotspot.

To reduce the noise that has often complicated this field, the Nature study used a preregistered multi-stage approach, combining whole-brain image-based meta-analysis with region-of-interest tests, Bayesian evidence estimates and checks for between-study heterogeneity. The authors report that most of the contributing studies used the Emotion Regulation Questionnaire, while a smaller number relied on the Cognitive Emotion Regulation Questionnaire. The dataset was dominated by picture-based tasks, although a few studies used videos, autobiographical cues or game-like paradigms. Nine of the studies had not been published before, and most of the contributing teams said they had not already run the exact primary analyses used in the paper, which reduces the risk of duplication in interpretation.

The consortium also placed the work in a transdiagnostic frame. Its inclusion criteria were limited to healthy participants in part to avoid the added variation that comes with psychiatric diagnoses and medication use, but the authors note that the same analytical logic could help future work in clinical samples. That matters because the wider field has increasingly focused on how reappraisal might be strengthened in treatment, whether through training, psychotherapy or neurofeedback. Separate reviews of real-time fMRI neurofeedback have found that healthy volunteers can often modulate activity in emotion-related brain regions, but that behavioural gains and neural effects vary substantially by protocol and population, limiting how far such methods can yet be generalised.

The Nature authors say the study’s open, collaborative design and large pooled sample allow a more precise look at the overlap between questionnaire-based reappraisal, subjective emotional change and amygdala down-regulation than most earlier reports. Their broader message is cautious rather than dismissive: cognitive reappraisal remains a central concept in affective neuroscience, but the biology behind it appears more complex, and perhaps less uniform, than simple models of a single regulatory circuit would imply. For researchers and clinicians alike, the study underscores the need to distinguish between how people say they regulate emotion, how they feel during regulation and how the brain responds while they do it.

Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.